Nanogold: Properties, Applications, and Surface Plasmon Resonance Explained

Gold at the nanoscale behaves nothing like the gold you see in jewellery. When gold is reduced to particles measuring just 1 to 100 nanometres, it undergoes dramatic changes in colour, reactivity, and even its interaction with light. These tiny particles – commonly referred to as nanogold or gold nanoparticles (AuNPs) – have become one of the most actively studied nanomaterials in science and medicine. From detecting diseases at the molecular level to killing cancer cells with targeted heat, nanogold sits at the intersection of physics, chemistry, and biology.

What makes nanogold unique? 🔗

Bulk gold is chemically inert, yellow, and conducts electricity. But when you shrink it down to the nanometre scale, everything changes. The size-dependent properties of gold nanoparticles set them apart from virtually all other materials. A solution of ~30 nm gold nanoparticles appears deep red, while larger particles (~100 nm) shift toward blue or purple hues. This dramatic colour change is not due to any dye or pigment – it is the result of a phenomenon called surface plasmon resonance (SPR), which governs how nanogold interacts with light.

Beyond optical changes, gold nanoparticles also exhibit altered solubility, increased catalytic activity, and high surface area-to-volume ratios. Their surfaces can be easily modified with polymers, small molecules, and biological recognition molecules, making them extremely versatile for applications in sensing, drug delivery, and imaging. These particles are typically synthesised through chemical reduction methods – such as citrate reduction of gold salts – giving researchers fine control over particle size and shape.

Surface plasmon resonance in nanogold 🔗

Surface plasmon resonance (SPR) is the defining optical feature of gold nanoparticles. It occurs when incoming light causes the conduction electrons on the nanoparticle surface to oscillate collectively at a specific resonant frequency. This resonance leads to exceptionally strong absorption and scattering of light at particular wavelengths – far more intense than what you would see with non-metallic particles of the same size.

How SPR works at the particle level 🔗

When a light wave hits a gold nanoparticle, its electric field displaces the cloud of free electrons on the particle surface. These electrons then oscillate back and forth in phase with the light wave. At a certain wavelength, this oscillation reaches maximum amplitude – that is the SPR peak. For spherical gold nanoparticles around 20 nm in diameter, the SPR absorption maximum sits near 520 nm (green light is absorbed, red light is reflected, so the solution looks red). As particle diameter increases toward 100 nm, the absorption maximum shifts to around 570 nm, moving the colour toward purple and blue.

Factors that influence SPR 🔗

SPR is not fixed – it is highly tuneable. Three main factors determine where the resonance peak falls:

Particle size: Larger nanoparticles have SPR peaks at longer (redder) wavelengths. Gold nanoparticles below approximately 2 nm do not exhibit measurable SPR at all.

Particle shape: Non-spherical shapes like nanorods, nanostars, and nano-urchins can shift the SPR peak dramatically – sometimes into the near-infrared region of the spectrum. Nanorods, for example, have two SPR modes (transverse and longitudinal) because their electrons oscillate differently along the short and long axes.

Local environment: The refractive index of the medium surrounding the particle also shifts the SPR peak. Moving particles from water to oil, for instance, causes a red-shift in the peak because the surrounding medium has a higher refractive index.

Why SPR matters for biosensing 🔗

The high sensitivity of SPR to changes in the local environment is what makes nanogold such a powerful tool for biosensing and diagnostics. When molecules bind to the surface of a gold nanoparticle, they change the local refractive index, which shifts the SPR peak. This shift can be detected using simple UV-visible spectroscopy. In practice, gold nanoparticles functionalised with antibodies or DNA probes can detect specific biomarkers – signalling the presence of a disease – simply by a change in the colour of the solution or a shift in the absorption spectrum. This principle is already used in common diagnostic tools such as lateral flow immunoassays, including home pregnancy tests.

Applications in medicine and technology 🔗

The tuneable optical properties, biocompatibility, and ease of surface functionalisation make gold nanoparticles exceptionally useful across medicine and high technology. Here are the key application areas.

Drug delivery 🔗

Gold nanoparticles have a high surface area-to-volume ratio, which means their surfaces can be loaded with hundreds of drug molecules, targeting agents, and protective polymers simultaneously. This makes them ideal nano-carriers. The drugs can be attached via covalent bonding or physical adsorption, and release can be triggered by stimuli like pH changes, enzymatic activity, or light exposure.

A notable example is the development of gold nanoparticle complexes carrying the chemotherapy drug oxaliplatin. Researchers found that platinum drugs tethered to gold nanoparticles showed significantly improved cytotoxicity against cancer cell lines compared to free drug molecules, likely because nanoparticle delivery enhances cellular uptake and retention. Furthermore, nanoparticle-based delivery allows drugs to passively accumulate in tumours through the enhanced permeability and retention (EPR) effect – a phenomenon where the leaky vasculature around tumours lets nanoparticles preferentially enter and stay in tumour tissue.

Cancer treatment: photothermal therapy 🔗

One of the most exciting clinical applications of nanogold is photothermal therapy (PTT). Gold nanoparticles – particularly nanoshells and nanorods with SPR peaks in the near-infrared (NIR) region – efficiently absorb NIR light and convert it into heat. Since NIR light (700-1000 nm) penetrates biological tissue relatively well, clinicians can shine this light onto a tumour containing accumulated gold nanoparticles. The particles heat up rapidly and destroy surrounding cancer cells through localised hyperthermia, while sparing healthy tissue.

Clinical trials have explored this approach. An early pilot study tested gold nanoshell particles (AuroShell) administered intravenously to patients with head and neck cancer, followed by targeted laser illumination. Such trials represent important steps toward bringing nanogold-based treatments into routine clinical practice.

Diagnostics and imaging 🔗

Gold nanoparticles scatter light intensely, making them excellent contrast agents for biological imaging under dark-field microscopy. They are also used in surface-enhanced Raman spectroscopy (SERS), where the electromagnetic field enhancement near the particle surface amplifies Raman signals by several orders of magnitude. This allows detection of molecules at very low concentrations without the need for fluorescent labels.

In clinical diagnostics, gold nanoparticles help detect biomarkers for heart disease, infectious agents, and various cancers. Their role in rapid diagnostic kits – where a colour change visible to the naked eye signals a positive result – has made them one of the most commercially successful nanomaterials to date.

Electronics and catalysis 🔗

In electronics, gold nanoparticles serve as conductive components in printable inks and nanoscale chip connections. As electronic devices continue to shrink, nanogold is becoming increasingly relevant for connecting resistors, conductors, and other circuit elements at the nanoscale. Gold nanoparticles are also active catalysts for selective oxidation reactions and have been explored for applications in fuel cells and environmental remediation.

Challenges facing nanogold 🔗

Despite all their promise, gold nanoparticles face several significant challenges that limit their broader adoption – especially in clinical settings.

Aggregation: the primary stability problem 🔗

Aggregation is the most common and most damaging issue. When gold nanoparticles clump together, their optical properties change dramatically – the SPR peak broadens, red-shifts, or disappears entirely. A solution that was once ruby red can turn blue or grey, signalling loss of individual particle behaviour. Aggregation can be triggered by changes in ionic strength, pH, or temperature of the surrounding solution. For example, adding salt to citrate-stabilised gold nanoparticles screens the electrostatic charges that keep particles apart, causing them to clump rapidly.

In biological environments, the problem is compounded. When gold nanoparticles enter blood or tissue fluids, proteins adsorb onto their surface forming a “protein corona.” This corona can alter the particle’s surface charge, trigger immune recognition, and promote aggregation – all of which reduce the effectiveness of the particles for drug delivery or imaging.

Stabilisation strategies 🔗

Researchers have developed several approaches to keep gold nanoparticles stable and well-dispersed:

PEGylation – attaching polyethylene glycol (PEG) chains to the nanoparticle surface – is the most widely used method. PEG creates a steric barrier that physically prevents particles from coming close enough to aggregate. It also improves biocompatibility and extends circulation time in the bloodstream.

Thiol-based ligands form strong gold-sulfur bonds on the particle surface, creating stable, long-lasting protective coatings. These ligands can be further functionalised with targeting molecules like antibodies or aptamers.

Polymer and biomolecule encapsulation – using materials like starch hydrogels or protein coatings – has also shown effectiveness. Studies have demonstrated that suspending gold nanoparticles in starch hydrogels can increase their stability by as much as 400% when exposed to high salt concentrations.

Other ongoing challenges 🔗

Beyond aggregation, there are additional hurdles. Scaling up production while maintaining uniform size and quality is difficult – what works in a small laboratory batch does not always translate to industrial volumes. Long-term toxicity remains under investigation; while gold itself is biocompatible, the coatings and ligands used in functionalisation may introduce toxicity risks. Regulatory approval for clinical use requires extensive safety data, and only a handful of nanogold-based therapies have reached clinical trials so far.

Future perspectives 🔗

The future of nanogold lies in multifunctional nanoparticle design – particles that can simultaneously diagnose, image, and treat disease in a single platform. Researchers are developing gold nanoparticles that combine drug delivery with photothermal therapy and real-time imaging, creating true “theranostic” agents.

Advances in synthesis techniques are enabling better control over particle shape, leading to novel geometries like nanostars and nanocages with enhanced optical properties. Stimulus-responsive designs – where drug release is triggered by light, pH, or temperature – are also gaining traction, allowing more precise control over when and where therapeutic payloads are delivered.

In environmental monitoring, gold nanoparticle-based sensors are being developed for detecting pollutants, heavy metals, and biological contaminants at extremely low concentrations. The sensitivity of SPR-based sensing platforms makes them particularly promising for field-deployable environmental testing where rapid results are critical.

As synthesis methods become cheaper, stabilisation techniques more robust, and regulatory pathways clearer, nanogold is positioned to move from research laboratories into widespread clinical and industrial use.

What do you think? Given the challenges of stability and scaling, which application of nanogold – cancer therapy, biosensing, or environmental monitoring – do you believe will see the most practical impact in the next decade? And how important is it to resolve toxicity concerns before expanding clinical use?

References

1. https://nanocomposix.com/pages/gold-nanoparticles-optical-properties
2. https://www.cytodiagnostics.com/pages/gold-nanoparticle-properties
3. https://www.nanopartz.com/Technical-Notes/All-About-Surface-Plasmon-Resonance.asp
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073740/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC3596176/
6. https://pubs.acs.org/doi/10.1021/ja908117a
7. https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/materials-science-and-engineering/biosensors-and-imaging/gold-nanoparticles
8. https://link.springer.com/article/10.1007/s11051-014-2376-4
9. https://advanced.onlinelibrary.wiley.com/doi/full/10.1002/adfm.202110253
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC7460011/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC10383270/